BRPI0519561A2 - composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide - Google Patents

composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide

Info

Publication number
BRPI0519561A2
BRPI0519561A2 BRPI0519561-6A BRPI0519561A BRPI0519561A2 BR PI0519561 A2 BRPI0519561 A2 BR PI0519561A2 BR PI0519561 A BRPI0519561 A BR PI0519561A BR PI0519561 A2 BRPI0519561 A2 BR PI0519561A2
Authority
BR
Brazil
Prior art keywords
packaging
pharmaceutical composition
thyroid hormone
pharmaceutical
thyraid
Prior art date
Application number
BRPI0519561-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Kyle E Brinkman
Dan Rutledge
Joseph R Bayman
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of BRPI0519561A2 publication Critical patent/BRPI0519561A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
BRPI0519561-6A 2004-12-27 2005-12-22 composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide BRPI0519561A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63932804P 2004-12-27 2004-12-27
US63934404P 2004-12-27 2004-12-27
PCT/US2005/047011 WO2006071844A2 (en) 2004-12-27 2005-12-22 Oxygen-impervious packaging and methods for storing thyroid hormone

Publications (1)

Publication Number Publication Date
BRPI0519561A2 true BRPI0519561A2 (pt) 2009-01-27

Family

ID=36615468

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519561-6A BRPI0519561A2 (pt) 2004-12-27 2005-12-22 composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide

Country Status (10)

Country Link
US (1) US20060183804A1 (enExample)
EP (1) EP1835897A2 (enExample)
JP (1) JP2008525527A (enExample)
KR (1) KR20070100720A (enExample)
AU (1) AU2005322023A1 (enExample)
BR (1) BRPI0519561A2 (enExample)
CA (1) CA2589283A1 (enExample)
IL (1) IL183824A0 (enExample)
MX (1) MX2007007860A (enExample)
WO (1) WO2006071844A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073759A2 (en) * 2006-12-07 2008-06-19 Eli Lilly And Company An article comprising prasugrel
US7645801B2 (en) * 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
US8375628B2 (en) * 2007-09-20 2013-02-19 Kamterter Products, Llc Seed testing method and apparatus
ES2994042T3 (en) 2009-02-26 2025-01-16 Glaxo Group Ltd Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
JP6081058B2 (ja) * 2009-03-19 2017-02-15 第一三共株式会社 包装により安定保存された固形製剤
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
ITMI20112066A1 (it) 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
CN107530311A (zh) 2015-02-03 2018-01-02 卡德门制药有限公司 稳定的曲恩汀制剂
US11077990B2 (en) * 2017-12-21 2021-08-03 Davion, Inc. Packaging system for medicated starch-based powder formulations
CA3086158A1 (en) * 2018-01-10 2019-07-18 Insys Development Company, Inc. Methods of stabilizing dronabinol

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2991437B2 (ja) * 1987-07-27 1999-12-20 カヌードメタルボックス パブリック リミテド カンパニー 包装に関する改良
EP0335520A1 (en) * 1988-03-12 1989-10-04 CarnaudMetalbox plc Improvements in and relating to packaging
US6709724B1 (en) * 1990-05-02 2004-03-23 W. R. Grace & Co.-Conn. Metal catalyzed ascorbate compounds as oxygen scavengers
WO1994009084A1 (en) * 1990-05-02 1994-04-28 Advanced Oxygen Technologies, Inc. Polymer compositions containing oxygen scavenging compounds
US5202052A (en) * 1990-09-12 1993-04-13 Aquanautics Corporation Amino polycarboxylic acid compounds as oxygen scavengers
ZA913312B (en) * 1990-05-02 1992-04-29 Zapata Industries Inc Polymer compositions containing oxygen scavenging compounds
US5364555A (en) * 1991-04-30 1994-11-15 Advanced Oxygen Technologies, Inc. Polymer compositions containing salicylic acid chelates as oxygen scavengers
US5211875A (en) * 1991-06-27 1993-05-18 W. R. Grace & Co.-Conn. Methods and compositions for oxygen scavenging
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
WO1994012590A1 (en) * 1992-11-24 1994-06-09 Commonwealth Scientific And Industrial Research Organisation Oxygen scavengers independent of transition metal catalysts
US5759653A (en) * 1994-12-14 1998-06-02 Continental Pet Technologies, Inc. Oxygen scavenging composition for multilayer preform and container
JP3562723B2 (ja) * 1996-09-23 2004-09-08 ビーピー・コーポレーション・ノース・アメリカ・インコーポレーテッド ビール及び他の用途のためのゼロ酸素透過性プラスチックボトル
US6083585A (en) * 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
US6863988B2 (en) * 1996-09-23 2005-03-08 Bp Corporation North America Inc. Oxygen scavenging monolayer bottles
JP3707899B2 (ja) * 1997-02-26 2005-10-19 株式会社大塚製薬工場 複室容器
JPH10287375A (ja) * 1997-04-14 1998-10-27 Material Eng Tech Lab Inc 酸素易変質性薬剤入り容器の包装体
US5981676A (en) * 1997-10-01 1999-11-09 Cryovac, Inc. Methods and compositions for improved oxygen scavenging
EP0939220B1 (de) * 1998-02-26 2003-11-12 ALSTOM (Switzerland) Ltd Verfahren zum sicheren Entfernen von Flüssigbrennstoff aus dem Brennstoffsystem einer Gasturbine sowie Vorrichtung zur Durchführung des Verfahrens
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
DE19830246A1 (de) * 1998-07-07 2000-01-13 Merck Patent Gmbh Pharmazeutische Zubereitung
US6333087B1 (en) * 1998-08-27 2001-12-25 Chevron Chemical Company Llc Oxygen scavenging packaging
CA2299934C (en) * 1999-03-03 2006-09-19 Kuraray Co., Ltd. Oxygen absorptive resin composition
US6454965B1 (en) * 1999-03-24 2002-09-24 Chevron Phillips Chemical Company Lp Oxygen scavenging polymers in rigid polyethylene terephthalate beverage and food containers
PL212687B1 (pl) * 1999-08-06 2012-11-30 Plastipak Packaging Pojemnik z tworzywa sztucznego
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
US6423776B1 (en) * 2000-05-02 2002-07-23 Honeywell International Inc. Oxygen scavenging high barrier polyamide compositions for packaging applications
GB2371498A (en) * 2000-08-03 2002-07-31 Johnson Matthey Plc Oxygen scavenging using PGM catalyst loaded grafted copolymer fibres
US6517776B1 (en) * 2000-11-03 2003-02-11 Chevron Phillips Chemical Company Lp UV oxygen scavenging initiation in angular preformed packaging articles
US6682791B2 (en) * 2001-02-07 2004-01-27 Sonoco Development, Inc. Packages and methods for differential oxygen scavenging
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US6410156B1 (en) * 2001-03-06 2002-06-25 Honeywell International Inc. Oxygen scavenging polyamide compositions suitable for pet bottle applications
US6793994B2 (en) * 2001-03-07 2004-09-21 Honeywell International Inc. Oxygen scavenging polymer compositions containing ethylene vinyl alcohol copolymers
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
US6544611B2 (en) * 2001-08-01 2003-04-08 Arteva North America S.A.R.L. Oxygen scavenging PET based polymer
US20030183801A1 (en) * 2002-03-28 2003-10-02 Hu Yang Porous oxygen scavenging material

Also Published As

Publication number Publication date
WO2006071844A2 (en) 2006-07-06
JP2008525527A (ja) 2008-07-17
KR20070100720A (ko) 2007-10-11
AU2005322023A1 (en) 2006-07-06
IL183824A0 (en) 2008-12-29
MX2007007860A (es) 2007-07-18
CA2589283A1 (en) 2006-07-06
US20060183804A1 (en) 2006-08-17
EP1835897A2 (en) 2007-09-26
WO2006071844A3 (en) 2006-10-05
WO2006071844A8 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
CY1122963T1 (el) Ουσια-φορεας φαρμακων και κιτ ουσιας-φορεα φαρμακων για αναστολη ινωσης
BRPI0512988A (pt) método para aumentar a meia-vida plasmática de uma molécula, composto, uso do mesmo, e, composição farmacêutica
BRPI0519561A2 (pt) composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide
ATE303178T1 (de) Acc-hemmer
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
BRPI0912229A2 (pt) mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
MXPA06008352A (es) Una composicion farmaceutica.
SG148857A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
CR8402A (es) Indazol-o-glucosidos sustitutos
RS52110B (en) DIPEPTIDIL PEPTIDASE INHIBITORS FOR TREATMENT OF DIABETES
NO20003472L (no) TTS som inneholder en antioksidant
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
DK1608346T3 (da) Lægemiddeltilförselssammensætninger af alfa-hydroxysyreester og fremgangsmåder til anvendelse heraf
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
PA8579901A1 (es) Bifenilcarboxamidas sustituidas con n-aril piperidina
AR038332A1 (es) Compuestos que son metabolitos del acido (3-{[(4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acetico, composiciones farmaceuticas que los contienen, y procedimiento de determinacion
AR006616A1 (es) Derivados carboxilicos utiles como inhibidores de los receptores de las endotelinas y composiciones farmaceuticas que los contienen
EA200702102A1 (ru) Пластинки, содержащие стероидные гормоны
EA200501164A1 (ru) Индазоламиды с аналгетической активностью
EA200701228A1 (ru) Стабильные композиции фенофибрата с эфирами жирных кислот
BR0308601A (pt) inibidores de carboxipeptidase b de plasma
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
ATE461694T1 (de) Pharmazeutische indapamid-zusammensetzung mit verzögerter freisetzung
UA91646C2 (ru) Соединения индола, способ их получения и фармацевтическая композиция (варианты), которая их содержит

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.